Total Debt for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's latest reported total debt is $350.89M USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingTotal DebtSwitch metric
Latest period
$350.89M
YoY change
+5.8%
5Y CAGR
+0.5%
Peak year (2019)
$505.16M
Latest annual
$444.06M
Total Debt history chart for Bio-Techne (TECH) from 1989 to 2025
Total Debt history table for Bio-Techne (TECH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $444.06M | +5.8% | ||
| 2024 | $419.54M | -7.8% | ||
| 2023 | $454.96M | +39.6% | ||
| 2022 | $325.97M | -22.5% | ||
| 2021 | $420.55M | -3.0% | ||
| 2020 | $433.53M | -14.2% | ||
| 2019 | $505.16M | +49.0% | ||
| 2018 | $339.00M | -3.1% | ||
| 2017 | $349.90M | +161.6% | ||
| 2016 | $133.76M | +15.3% | ||
| 2015 | $116.05M | +796.4% | ||
| 2014 | $12.95M | — | ||
| 2013 | $0 | — | ||
| 2012 | $0 | — | ||
| 2011 | $0 | — | ||
| 2010 | $0 | — | ||
| 2009 | $0 | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | -100.0% | ||
| 2006 | $13.43M | -8.1% | ||
| 2005 | $14.62M | -7.8% | ||
| 2004 | $15.86M | -7.2% | ||
| 2003 | $17.09M | -5.3% | ||
| 2002 | $18.05M | -4.7% | ||
| 2001 | $18.94M | -4.2% | ||
| 2000 | $19.76M | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | -100.0% | ||
| 1992 | $2.10M | +162.5% | ||
| 1991 | $800,000 | -27.3% | ||
| 1990 | $1.10M | +83.3% | ||
| 1989 | $600,000 | — |
Total Debt values are taken from Bio-Techne's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Bio-Techne (TECH) total debt is $444.06M – grew 5.8% year-over-year.
Through 2020–2025 (5 years), Bio-Techne total debt delivered a +0.5% annualised rate; with the latest reading among the more recent periods of the dataset.
Across the available history, total debt reached its high of $505.16M in 2019 and its low of $0 in 1993.
Bio-Techne (TECH) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $52.57B.
Bio-Techne Total Debt by Year
Bio-Techne Total Debt 2025: $444.06M
Bio-Techne total debt in 2025 was $444.06M, grew 5.8% from 2024.
Bio-Techne Total Debt 2024: $419.54M
Bio-Techne total debt in 2024 was $419.54M, declined 7.8% below 2023.
Bio-Techne Total Debt 2023: $454.96M
Bio-Techne total debt in 2023 was $454.96M, surged 39.6% from 2022.
Bio-Techne Total Debt 2022: $325.97M
Bio-Techne total debt in 2022 was $325.97M, declined 22.5% below 2021.
Bio-Techne Total Debt 2021: $420.55M
Bio-Techne total debt in 2021 was $420.55M.
See more financial history for Bio-Techne (TECH).
Sector peers — Total Debt
Companies in the same sector as Bio-Techne, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Bio-Techne's total debt?
- Latest reported total debt for Bio-Techne (TECH) is $350.89M (period ending December 31, 2025).
How has Bio-Techne total debt changed year-over-year?
- Bio-Techne (TECH) total debt changed +5.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne total debt?
- Bio-Techne (TECH) total debt compound annual growth rate is +0.5% over the most recent 5 years available.
When did Bio-Techne total debt hit its highest annual value?
- Bio-Techne total debt reached its highest annual value of $505.16M in 2019.
What was Bio-Techne total debt in 2024?
- Bio-Techne (TECH) total debt in 2024 was $419.54M.
What was Bio-Techne total debt in 2025?
- Bio-Techne (TECH) total debt in 2025 was $444.06M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.